Celia Jonsson‐Oldenbüttel

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

GlaxoSmithKline (United States)(Current)

MUC Research (Germany)

Goethe Institut

ViiV Healthcare (United Kingdom)

Inserm

Celia Jonsson‐Oldenbüttel is an author at GlaxoSmithKline (United States) specializing in antiretroviral therapy, antiviral pharmacotherapy, and clinical pharmacology.

Publications per year

2021–2024

Publications

Not Recommended, But Done: Breastfeeding with HIV in Germany

Lila Haberl, Franz Audebert, Cornelia Feiterna‐Sperling et al. · AIDS Patient Care and STDs · 2021 · 26 citations

Public Health, Maternal Health, Breastfeeding +13

Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings

Celia Jonsson‐Oldenbüttel, Jade Ghosn, Marc van der Valk et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2024 · 17 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +15

Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

Cassidy A. Gutner, Laurent Hocqueloux, Celia Jonsson‐Oldenbüttel et al. · Journal of the International AIDS Society · 2024 · 11 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

1–3 of 3